REJORYS
Live / Applied — First extension granted (statement of use) (as of 10 Nov 2025)
What this means for you
Not registered yet, but its 19 Nov 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98861509
- Mark type
- Stylized text
- Filed
- 19 Nov 2024
- Published for opposition
- 17 Jun 2025
- Attorney of record
- Karl M. Zielaznicki
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune disorders
Owner
- Takeda Pharmaceuticals International AG, Glattpark-Opfikon, CH
- Takeda Pharmaceuticals International AG, Glattpark-Opfikon, CH
Prosecution history
- 11 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Nov 2025 — SOU EXTENSION 1 GRANTED
- 10 Nov 2025 — SOU EXTENSION 1 FILED
- 10 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Jun 2025 — PUBLISHED FOR OPPOSITION
- 11 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 May 2025 — ASSIGNED TO EXAMINER
- 04 Feb 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Feb 2025 — TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
- 04 Feb 2025 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 27 Jan 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Jan 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS